USA / U-Turn as Biden Pledges Support for Waiver on COVID-19 Vaccine IP
In a shock move, Joe Biden’s administration looks set to support a waiver on intellectual property (IP)…
Americas
Colombia / $25 million US Cannabis Deal; COVID-Related Consumer Health Boom; Bayer Prioritises Innovation
The latest news from the Colombian pharma market, including a new (legal) US cannabis deal; Bayer’s updated…
Mexico / Novartis Gets “Aggressive”; Country President Foresees Outcome-Based Contracts
During a year where the Mexican economy shrank 8.5 percent, Novartis Mexico experienced a modest one percent growth…
USA / Importance of the Patient Voice in Drug Development: Eosinophilic Esophagitis as a Case Example
Writing in the May edition of DIA’s Global Forum magazine, Erica Lyons, Sarrit Kovacs, Matthew Kowalik, and…
Colombia / Top 10 Pharma Companies
The Top 10 pharma companies in the Colombian pharma market ranked by operating income for the year 2020. Local…
Canada / Top 10 Pharma Companies 2020 Ranking
The Top 10 companies in the Canadian pharma market for 2020, ranked by revenues in USD billions. J&J takes the…
In Conversation
Stephen Farr – President & CEO, Zogenix
Zogenix’s Dr Stephen Farr shares his remarkable career journey from academia to industry, the company’s transition from pain therapeutics into rare diseases, product launch strategies, access and affordability issues, and…
Tatsuya Kaihara – Corporate Officer, Head of North…
Tatsuya Kaihara, head of US operations for Japanese eyecare specialist Santen, describes his excitement at bringing two new ophthalmic advancements to the US market, the similarities, differences, and synergies of…
Héctor Orellana – VP North Latin America, Medtronic
Medtronic’s VP for North Latin America, Héctor Orellana, outlines the largest company’s new vision for that region, their efforts and challenges to continue gaining market access, and explains why the…
Latest Reports
USA Pharma Report 2020
- 2020
The inaugural edition of the US Healthcare and Life Sciences Review has collated comments and insights from stakeholders across regulators, health insurers, pharma and biotech companies, as well as patient and industry associations, to provide an incisive snapshot of the US healthcare industry during one of its most defining periods, look at how far the sector has come and ultimately, how much further still it has to go, in order to achieve its fundamental mission: delivering innovative, quality and life-changing therapies in an accessible and sustainable manner. This exclusive new report is an extensive compilation of insights into the…
Latest Reports
USA Pharma Data Report October 2020
- 2020
HCLS Review USA Data is an extensive compilation of data and infographics from the world’s largest and most important pharmaceutical market. US sales of drugs accounted for 48 percent of the global market for pharmaceuticals in 2019 and pharma market spending is on the rise, with Americans projected to be spending between USD 635 and 655 billion on medicine by 2023. Moreover, the USA is the world’s largest research and development engine, with an estimated USD 60 billion spent every year for this purpose, helping create the innovative treatments of tomorrow. This exclusive new 19-page report contains up-to-date information…
Latest Reports
Puerto Rico Pharma Report January 2020
- 2020
Puerto Rico has a stronger healthcare manufacturing footprint than any other US jurisdiction or State, with 50 pharma and 30 medical device sites dotted throughout the island. This footprint represents around 30 percent of Puerto Rico’s GDP and two of its major exports. Several multinational firms are doubling down on their commitment to manufacturing on Puerto Rico and an increasing number of small and medium-sized companies from Europe, Asia and Latin America are choosing to situate manufacturing sites there. This report looks at the rationale behind these commitments, how Puerto Rico is innovating within pharmaceutical manufacturing, and the…
Latest Reports
Medical Cannabis in Canada Report 2018
- 2018
Latest Reports
Canada Pharma Report 2018
- 2018
Latest Reports
Ecuador Pharma Report 2018
- 2018
With a fresh, business-minded administration in place, economic growth, a burgeoning middle class, and a greater openness towards cooperation between the public and private sectors, the fundamentals are there for Ecuador’s life sciences industry to shine. Medicine sales per capita are extremely high for Latin America and the dollarization of the economy is helping soothe investor nerves around currency depreciation. However, despite heavy investment in public health infrastructure projects, the country’s reputation for instability and insularity has tended to scare off potential investors. Labyrinthine market access regulations persist and Ecuador lags behind it neighbors in terms of available…
Latest Reports
Brazil Pharma Report 2018
- 2018
With an exit from a period of recession in 2017, a new era of change and positivity is underway in Brazil. Stakeholders from across the public and private sectors are pulling together through strategic partnerships and dialogues to increase both the quantity and quality of the healthcare provided to the 160 million Brazilians who rely on public healthcare as well as the 47 million who are privately insured. Topics covered in this comprehensive report include the opportunities identified by MNCs in Brazil; regulatory upgrades and shifts in government priorities; the strategies and successes of some of Brazil’s standout…
Latest Reports
Canada Pharma Report
- 2018
With economic prosperity, political stability and significant growth prospects, Canada has much to admire. However, Canadians still lack universal drug coverage and Canadian health innovation has lagged behind that of the world leaders in this area. This report explores how these discrepancies are being remedied; including state R&D investment initiatives, increased inter-stakeholder dialogue, and the new strategies of MNCs in Canada. Also featured are the movers and shakers among Canada’s broad spectrum of local companies whose work is helping the nation regain its place at the top table of global healthcare and life sciences.
Latest Reports
Colombia Pharma Report
- 2017
With steady GDP growth, political stability and the best healthcare system in Latin America, Colombia’s life sciences industry has all the ingredients for success laid out before it. Indeed, with the domestic pharmaceutical market set to grow at a rate of around 7.3 percent and reach a USD 7.1 billion valuation by 2020, coupled with a booming medical device market set to reach USD 1.8 billion in the same time frame, Colombia is carving out a name for itself as the new place to be. This report features interviews with the representatives of numerous multinational companies eager to capitalize…
Latest Reports
Mexico Pharma Report
- 2017
Meanwhile the country’s newly appointed minister of health has been audacious in radically reshuffling the rules of the game to place public healthcare provision “firmly on a pathway to sustainability.” “A corner has been turned and we are well on the way to establishing the enabling environment for an enduring healthcare system that is viable over the long run and can still accommodate the reimbursement of the latest generation of innovative treatments,” explains Minister Nicolae Bănicioiu
Focus on USA
NORD’s Breakthrough Summit: Listening to the Rare Disease…
The National Organization for Rare Disorders (NORD) is set to host its annual Rare Diseases and Orphan Products Breakthrough Summit on October 18-19th. Ahead of the Summit, the Chair of…
PhRMA COO: Removing Protections in Medicare Would Harm…
PhRMA’s Lori Reilly warns that, as US policymakers seek to reduce drug prices, they must avoid policies that reduce access and choice. America is the centre of cutting-edge biopharmaceutical…
Read more from USA >>
Focus on Puerto Rico
New Puerto Rico Pharma Report January 2020 Out Now
Puerto Rico had to rebuild itself – in many cases quite literally – after the devastation wrought by Hurricane Maria in 2017. However, despite the havoc that Maria brought to…
Company Spotlight: Puerto Rico’s Quality &…
When life sciences companies decide to transfer the production of new drug to Puerto Rico, extend an existing production line, or simply sustain existing operations, they can count on the…
Read more from Puerto Rico >>
Focus on Colombia
Colombia Pharma News: $25 million US Cannabis Deal;…
The latest news from the Colombian pharma market, including a new (legal) US cannabis deal; Bayer’s updated regional strategy; a pandemic-induced OTC product boom; Faes Farma’s growth; and why prostate…
Colombian Tecnoquimicas’ USD 200 Million Manufacturing…
Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion pharma market, announced a swathe of manufacturing investments in late 2019, taking its spending on plants and equipment in…
Read more from Colombia >>
Focus on Canada
Concrete Steps Toward National Pharmacare in Canada
Writing in the September edition of DIA's Global Forum magazine, Dr Judith Glennie examines the specific steps that have been taken in the journey towards a National Pharmacare program in…
Canada: Federal Consultations on a National Strategy for…
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health Canada's consultation with Canadians on what a national strategy for high-cost rare disease…
Read more from Canada >>
Focus on Brazil
Brazil Pharma News: EMS Sales Soar; Irregularities in Indian…
The latest news from Brazilian pharma, including an investigation into the country’s deal with Indian lab Bharat Biotech to purchase COVID-19 vaccines; the IP and regulatory challenges around personalised medicine…
Brazil’s Largest Private Pharma Company Under Threat
Founded in 1950, EMS is one of the top two domestic pharma companies in Brazil. As a key player in the largest and most populous nation in Latin America, the…
Read more from Brazil >>
Focus on Mexico
Novartis Mexico Gets “Aggressive”; Country President…
During a year where the Mexican economy shrank 8.5 percent, Novartis Mexico experienced a modest one percent growth which Country President Fernando Cruz, qualified as “reasonably good” considering the impacts…
Mexico Pharma News: Bayer Targets Cancer; Novartis Gets…
The latest news from Mexican pharma, including Bayer’s big bet on oncology and Novartis’ aggressive expansion strategy as well as updates on the country’s vaccination drive, including the upcoming rollout…
Read more from Mexico >>
USA / PhRMA COO: Removing Protections in Medicare Would Harm Seniors
PhRMA’s Lori Reilly warns that, as US policymakers seek to reduce drug prices, they must avoid policies that…
LATAM / Chilean Healthcare Reform: “Deep & Comprehensive” but Unable to Calm the Protests?
Against a backdrop of protests against Chile’s market-dominant socio-economic model, President Sebastián Piñera…
The Long Read / Dominican Republic: A Hidden Manufacturing Gem
The rise of the Dominican Republic as a regional medtech manufacturing hub might have come as a surprise to many,…
USA / FDA Calls for Federal Investigation of Itself on Aduhelm; Funding Boost for Medicare, Medicaid, ObamaCare; Questions over Benefits of New Science Agency
The latest from US health care policy, including the Senate budget deal funding for a range of major health care…
USA / NORD’s Breakthrough Summit: Listening to the Rare Disease Patient Voice
The National Organization for Rare Disorders (NORD) is set to host its annual Rare Diseases and Orphan Products…
Mexican Healthcare Reforms / Question Marks Remain
The election of populist President Andres Manuel Lopez Obrador (AMLO) on 1 July 2018 heralded a new era of hope and…